Rank #1882CUE

Cue Biopharma, Inc.

$0.29

-1.31% (Daily)

Market Cap

$26.75M

Revenue

$7.10M

Rank by MCap

#1882

Sector

Healthcare

Industry

Biotechnology

CEO

Dr. Usman Azam M.D.

Headquarters

Boston, MA

Employees

About Cue Biopharma, Inc.

Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops a novel class of injectable therapeutics to selectively engage and modulate targeted, disease relevant T cells in the United States. Its lead drug product candidate is the CUE-401, a novel approach to induce and expand antigen specific Tregs for regulating disease causing autoreactive Teff cells which is in preclinical trial; and CUE-501, a treatment of autoimmune disease via anti-viral T cell-mediated depletion of B ce...